CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Editas Medicine Inc. (EDIT) on Monday reported a loss of $5.6 million in its fourth quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 6 cents.
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.
The genome editing company posted revenue of $24.7 million in the period, also topping Street forecasts. Four analysts surveyed by Zacks expected $6.5 million.
For the year, the company reported a loss of $160.1 million, or $1.80 per share. Revenue was reported as $40.5 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EDIT at https://www.zacks.com/ap/EDIT
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
